Azienda Socio Sanitaria Territoriale Nord Milano

At Azienda Socio Sanitaria Territoriale Nord Milano, clinical research in cardiovascular disease focuses on preventing major heart and vascular events in people at elevated risk, including those with atherosclerotic cardiovascular disease and elevated lipoprotein(a).

• Testing new therapies aimed at lowering the risk of serious cardiovascular outcomes
• Studying treatment options for primary prevention in high-risk patients
• Evaluating approaches designed to improve long-term cardiovascular protection

This work supports better prevention strategies by assessing whether newer treatments can reduce the chance of heart attack, stroke, and related complications.

Research in nutritional and metabolic diseases at this hospital centers on lipid and triglyceride disorders, with studies involving severe hypertriglyceridemia and elevated lipoprotein(a).

• Exploring therapies for abnormal blood fat levels
• Assessing whether treatment can improve triglyceride control
• Looking at new options for inherited or difficult-to-treat lipid disorders

These trials are designed to help determine whether emerging treatments can improve metabolic health and reduce the burden of cardiovascular risk linked to lipid abnormalities.

Within the area of congenital and hereditary diseases, the site is also investigating conditions with a strong genetic component, especially elevated lipoprotein(a), which is an important inherited risk factor for cardiovascular disease.

• Studying inherited contributors to cardiovascular risk
• Evaluating therapies that target genetically influenced lipid disorders
• Improving understanding of how genetic risk can be managed in routine care

By focusing on these conditions, the research aims to clarify whether targeted treatment can better address inherited risk and support earlier prevention.

The SC Nefrologia e Dialisi team is also studying care for people with end stage kidney disease on chronic dialysis, with attention to potassium management and nutrition.

• Evaluating treatment strategies to support safer potassium control
• Assessing whether dietary restrictions can be reduced without increasing risk
• Improving quality of life and nutritional well-being in dialysis patients

This research seeks practical ways to balance kidney-related safety with day-to-day dietary flexibility for patients living with chronic dialysis.